KR

Kuldeep Ratanchand Chauhan

Director Director DIN 06935245
DIN 06935245 First appointment Sep 2014 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Sep 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Kuldeep Ratanchand Chauhan

Data last updated:

Kuldeep Ratanchand Chauhan was a Director at Gpax Pharmaceuticals Private Limited (2014). The company operates in Pharma.

DIN 06935245
Primary Designation Director
Industry Pharma
First Appointment 30 Sep 2014

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Gpax Pharmaceuticals Private Limited U24233MH2014PTC258452
Director30 Sep 20142014₹18.67 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Gpax Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kuldeep Ratanchand Chauhan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kuldeep Ratanchand Chauhan

Kuldeep Ratanchand Chauhan was first appointed on 30 Sep 2014 as Director at Gpax Pharmaceuticals Private Limited.

Kuldeep Ratanchand Chauhan held 1 earlier board appointment: Gpax Pharmaceuticals Private Limited (Director, 30 Sep 2014 to 07 Nov 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available